MRNA Jan 2024 125.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:33AM EDT. Market open.
| Previous close | 56.35 |
| Open | 56.35 |
| Bid | 64.00 |
| Ask | 67.25 |
| Strike | 125.00 |
| Expiry date | 2024-01-19 |
| Day's range | 56.35 - 56.35 |
| Contract range | N/A |
| Volume | |
| Open interest | 104 |
- Editor's pickYahoo Finance Video
The timeline of the FDA's ban on Juul vaping products
Yahoo Finance health reporter Anjalee Khemlani outlines the events surrounding the FDA's ban on Juul products and e-cigarettes, as well as Pfizer's Paxlovid COVID-19 treatment pill receiving an Emergency Use Authorization from the FDA.
- Editor's pickYahoo Finance Video
COVID-19 subvariants may evade vaccine protection, giant snails pose health risk in Florida
Yahoo Finance's health care reporter Anjalee Khemlani breaks down the latest health news, including risks from the BA.5 and BA.4 COVID subvariants and giant African snails that have been spotted in Florida.
- Motley Fool
This May Be Pfizer's Key to Long-Term Vaccine Dominance
Pfizer (NYSE: PFE) is already the leader in the coronavirus vaccine space. Rival Moderna (NASDAQ: MRNA) has a significant position in the market. Latecomer Novavax (NASDAQ: NVAX) could also take market share in the months to come.
© 2022 Yahoo. All rights reserved.
